| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-06-01 | NCT07617922 Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07416968 | Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For… | Overactive Bladder (OAB) | Recruiting |
| NCT06465576 | Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children… | Urinary Incontinence in Children | Active, Not Recruiting |
| Phase 3 | |||
| NCT06551246 | Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime… | Urinary Incontinence in Children | Recruiting |
| Phase 2 | |||
| NCT01530373 | Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients | Hot Flashes | Recruiting |
| NCT07617922 | Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms | Ureteral Stent-Related Symptoms | Recruiting |
| Not specified | |||
| NCT07305298 | Mirabegron in Patients With Age-Related Macular Degeneration | Dry AMD | Not Yet Recruiting |